How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

Allay Therapeutics’ Phase 2B Clinical Study Supports Ability of ATX101 To Deliver Four Weeks of Sustained Post-surgical Pain Relief

calendar_today April 11, 2024 person Chris Railey domain allay-therapeutics

Results inform design of pivotal Phase 2B study for potentially first ultra-sustained analgesic product Study…

open_in_new Read original post